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Abstract
The inflamed synovial tissue (ST) of rheumatoid arthritis (RA) is characterized by the se-
lective accumulation of interferon gamma-producing Th1-type CD4+ T cells. In this study, we
investigated whether the predominance of Th1-type CD4+ cells in the ST lesion is mediated by
their selective recruitment through Th1 cell-associated chemokine receptors CXCR3 and CCR5.
The lymphocyte aggregates in the ST of RA contained a large number of CD4+ T cells, which
mostly expressed both CXCR3 and CCR5, but not CCR4. In contrast, the frequencies of CD4+
and CD8+ T cells expressing CXCR3 and CCR5 in the blood were significantly decreased in RA
patients, compared with healthy controls (HC), although there was no difference in the frequencies
of CCR4-expressing CD4+ and CD8+ T cells between RA and HC. CXCR3, CCR5, and CCR4
expression in blood CD4 + T cells and CXCR3 expression in CD8+ T cells were increased after
interleukin-15 (IL-15) stimulation. Therefore, the distribution of Th1-type CD4+ T cells into the
ST from the blood in RA may be associated with the local expression of chemokines, both CXCR3
and CCR5 ligands, and IL-15 may play a role in enhancing these chemokine receptors on CD4+
T cell infiltrates.
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he interaction of chemokines and their recep-
tors play an important role in the migration of 
speciﬁ c leukocyte subpopulations.  The chemokine 
receptors CXCR3 and CCR5 are preferentially 
expressed in activated Th1 cells that can produce 
interferon-ｺ (IFN-ｺ),  tumor necrosis factor ｹ (TNF-
ｹ),  and interleukin-2 (IL-2) [1,  2ﾝ7].  In contrast, 
receptors such as CCR4 are expressed on IL-4- and 
IL-5-producing Th2 cells [4,  8,  9].  In the early 
pathway of Th1 and Th2 cell diﬀ erentiation, 
CXCR3＋CCR4－ and CXCR3－CCR4＋ T cells have 
been shown to express the Th1- and Th2-speciﬁ c 
transcription factors T-bet and GATA-3,  respec-
tively [10].  The association between CXCR3 and 
CCR5 expression in Th1 cells remains obscure,  but 
CXCR5 expression has been shown to be induced 
later during CXCR3＋ memory CD4＋ T cell diﬀ eren-
tiation [11].  Furthermore,  recent evidence indicates 
that chemokine receptors are involved in T-cell 
costimulation [12].  The ligands for CXCR3 include 
monokine induced by IFN-ｺ (Mig),  IFN-ｺ-inducible 
protein of 10 kDa (IP-10),  and IFN-inducible T-cell 
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ｸ chemoattractant (I-TAC),  and CCR5 ligands 
include regulated upon activation of normal T cell 
expressed and secreted (RANTES),  macrophage 
inhibitory protein 1ｸ (MIP-1ｸ),  and MIP-1ｹ [2].
　　Rheumatoid arthritis (RA) is a chronic inﬂ amma-
tory disease that primarily aﬀ ects multiple synovial 
joints.  The inﬂ amed synovial membrane is character-
ized by massive inﬁ ltration with lymphocytes and 
macrophages,  and lymphocyte aggregates consists 
primarily of CD4＋ T cells that can produce the Th1 
cytokines IFN-ｹ and IL-17 [13ﾝ17].  Consistent with 
the Th1 predominance,  studies of the expression of 
chemokines and chemokine receptors in synovial tis-
sue (ST) samples from RA patients have demon-
strated that both CXCR3 and CCR5 are strongly 
expressed in T-cell inﬁ ltrates [3,  18,  19],  and that 
their ligands are abundantly produced by macro-
phages and synovial ﬁ broblasts [20ﾝ22].  In the ST, 
where IL-2 is deﬁ cient,  T-cell activation is thought 
to be mediated at least in part by IL-15,  which 
shares the ｹ and ｺ chains of the IL-2 receptor. 
IL-15 stimulates macrophage production of TNF- ｸ 
through T-cell activation [23] as well as oligoclonal 
T-cell expansion [24].
　　In this study,  we determined the expression of 
CXCR3,  CCR5,  and CCR4 in CD4＋ and CD8＋ 
T-cell inﬁ ltrates in the ST of RA,  and then exam-
ined peripheral blood CD4＋ and CD8＋ T cells from 
RA patients for the frequencies of their chemokine 
receptor expression.  In addition,  we examined the 
eﬀ ects of IL-15 stimulation on T-cell chemokine 
receptor expression,  since IL-15 has been shown to 
induce T-cell expression of CCR4 and CCR5 [25].
Materials and Methods
　　Patients and samples.　 The total patient pop-
ulation consisted of 32 patients with RA (25 women 
and 7 men ; mean ± SD age 59.1 ± 11.3 years and 
mean disease duration 8.9 ± 1.4 years),  diagnosed 
according to the revised 1987 criteria of the 
American College of Rheumatology (formally,  the 
American Rheumatism Association).  Most patients 
were receiving nonsteroidal anti-inﬂ ammatory drugs 
(NSAIDs),  prednisolone (ｦ 10 mg/day),  and disease-
modifying anti-rheumatic drugs (DMARDs).  Serum 
C-reactive protein (CRP) levels were 24.5 ± 29.9 mg/
liter,  and IgM class rheumatoid factor (RF) was posi-
tive in 24 patients (titer 76.7 ± 85.9 units/ml). 
Twenty-six healthy volunteers (10 women and 16 
men) matched for age served as controls.  ST samples 
were obtained from 3 patients with RA (2 women and 
1 man ; 51,  71,  and 74 years old ; and disease dura-
tion 8,  17,  and 20 years) at the time of surgical 
treatment.  These patients were all receiving 
NSAIDs,  5 mg/day of prednisolone,  and DMARDs, 
showing CRP levels of 15 ± 4 mg/liter and positive 
RF (titer 69.4 ± 25.3 U/ml).  All the patients gave 
informed consent.
　　Two-color immunofluorescent stain-
ing.　 Cryostat sections (4 µm) from RA ST sam-
ples were ﬁ xed in acetone and blocked with 1.5ｵ 
normal horse serum in phosphate-buﬀ ered saline 
(PBS).  ST sections were incubated with 10 µg/ml of 
mouse anti-CXCR3 or mouse anti-CCR5 monoclonal 
antibody (mAb),  followed by ﬂ uorescein isothiocya-
nate (FITC)-conjugated horse anti-mouse antibody 
(polyclonal Ab),  FITC-conjugated mouse anti-CCR4 
mAb,  goat anti-CD4 (R&D systems,  Minneapolis, 
MN,  USA),  or anti-CD8 (polycolonal Ab) (Santa 
Cruz,  CA,  USA),  followed by incubation with rho-
damin-conjugated rabbit anti-goat (polycolonal Ab), 
and isotype control mAb.  The double immunoﬂ uores-
cence of sections was examined with an LSM510 
inverted laser-scanning confocal microscope (Zeiss, 
Jena,  Germany) and illuminated with 488 nm and 
568 nm of light.  Images decorated with FITC and 
rhodamine were recorded simultaneously through 
separate optical detectors with a 530-nm band-pass 
ﬁ lter and a 590-nm long-pass ﬁ lter,  respectively. 
Pairs of images were superimposed for colocalization 
analysis,  and chemokine receptor expression in 
CD4＋ and CD8＋ T cells was quantiﬁ ed using 
OPTIMAS software.
　　Flow cytometric analysis.　 Peripheral blood 
mononuclear cells (PBMCs) were prepared from hep-
arinized blood samples by centrifugation over Ficoll-
Hypaque density gradients (Pharmacia,  Uppsala, 
Sweden).  PBMCs in 1ｵ heat-inactivated fetal calf 
serum (Life Technologies,  Gaithersburg,  MD)/PBS 
were incubated with FITC-conjugated anti-CXCR3 
(Dako,  Kyoto,  Japan) or anti-CCR4 mAb (Kyowa 
Hakko,  Tokyo,  Japan),  phycoerythrin (PE)-
conjugated mouse anti-CCR5 mAb (Becton Dickinson, 
Franklin Lakes,  NJ,  USA),  or Chlorophyll-Protein 
(Per-CP)-conjugated anti-CD4 or anti-CD8 (Becton 
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Dickinson,  Franklin Lakes,  NJ,  USA),  or isotype-
matched control mAb.  Flow cytometric analysis was 
performed on a FACScan ﬂ ow cytometer (Becton 
Dickinson) by selective gating of lymphocytes based 
on parameters of forward and side light scatter.
　　T-cell stimulation with IL-15.　 PBMCs,  at 
a density of 1 × 106 cells/ml in RPMI 1640 medium 
(Life Technologies,  Gaithersburg,  MD,  USA) with 
10ｵ FCS,  were incubated with 10 ng/ml of recom-
binant human IL-15 (Pepro Tech,  Rocky Hill,  NJ, 
USA) in 24-well plates (Corning,  Corning,  NY, 
USA) at 37 ℃ in a humidiﬁ ed atmosphere containing 
5ｵ CO2.  Cells were harvested 7 days later and mea-
sured for the frequencies of CXCR3,  CCR5,  and 
CCR4 expression in CD4＋ and CD8＋ T cells by ﬂ ow 
cytometric analysis.
　　Colorimetric (MTT) assay for cell 
survival.　 PBMCs,  at a density of 1 × 106 in 
100 µl of RPMI 1640 with 10ｵ FCS in 96-well 
plates (Corning,  NY,  USA) were incubated with or 
without 10 ng/ml of IL-15.  After 7 days of incuba-
tion,  the cell survival was determined by MTT assay, 
according to the manufacturer’s instructions (Chem-
icon,  Temecula,  CA,  USA).  Cell survival with 
IL-15 was expressed by the relative index (the 
absorption of cultures with IL-15 minus that of the 
blank/the absorption of cultures without IL-15 minus 
that of the blank).
　　Statistical analysis.　 Data were expressed as 
the mean ± SEM of the number of samples evaluated. 
The statistical signiﬁ cance of deference between the 
2 groups was determined by the Mann-Whitney U 
test or the Wilcoxon signed rank test.  P values less 
than 0.05 were considered signiﬁ cant.
CD4/CXCR3 CD4/CCR5 CD4/CCR4
CD8/CXCR3 CD8/CCR5 CD8/CCR4
Fig. 1　　Expression of CXCR3,  CCR5,  and CCR4 in CD4＋ and CD8＋ T cells in the synovial tissue (ST) of rheumatoid arthritis (RA). 
ST sections from RA patients were stained with mouse anti-CXCR3 or anti-CCR5 antibody (Ab),  followed by incubation with FITC-
conjugated anti-mouse IgG Ab,  or FITC-conjugated anti-CCR4 Ab,  and then with goat anti-CD4 or anti-CD8 Ab,  followed by incubation 
with rhodamine-conjugated anti-goat IgG Ab.  Two-color immunoﬂ uorescence confocal images were obtained for chemokine receptors 
and the CD4 or CD8 antigen (green and red staining,  respectively).  The 2 images were superimposed,  and double-positive cells are 
shown in yellow.  Representative staining patterns of chemokine receptors in CD4＋ and CD8＋ T cell inﬁ ltrates are shown.  Similar stain-
ing patterns were obtained in additional analyses with 2 synovial tissue samples from diﬀ erent patients.
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Results
　　CXCR3 and CCR5 expression in CD4＋ 
T-cell inﬁ ltrates in the ST of RA.　 To 
determine the signiﬁ cance of Th1 cell-associated 
chemokine receptors in CD4＋ and CD8＋ T-cell 
subpopulations in the ST,  coexpression of the 
receptors CXCR3,  CCR5,  and CCR4,  and the 
surface markers CD4 and CD8 in ST samples from 
3 RA patients were analyzed by 2-color immu-
noﬂ uorescence labeling.  Representative staining 
patterns of CXCR3,  CCR5,  and CCR4 expression 
in CD4＋ and CD8＋ T cells are shown in Fig.  1. 
CD4＋ T cells were densely localized in the sublining 
layer,  forming the lymphoid aggregate surrounding 
blood vessels,  whereas CD8＋ T cells were sparsely 
distributed in the periphery.  The majority of CD4＋ 
T cells in the germinal center expressed both 
CXCR3 and CCR5.  In contrast,  CCR4 expression 
was rarely observed in the ST.
　　To quantitatively analyze CXCR3,  CCR5 and 
CCR4 expression in the CD4＋ and CD8＋ T-cell 
inﬁ ltrates of RA,  the ﬂ uorescence-stained area of 
chemokine receptors in the lymphoid aggregates was 
measured by OPTIMAS software.  ST samples from 
the RA patients studied showed a predominance of 
CD4＋ T cells (mean ± SEM ; 53.1 ± 3.9ｵ) over 
CD8＋ T cells (7.8 ± 2.1ｵ).  Both CD4＋ and CD8＋ 
T-cell subpopulations expressed high levels of 
CXCR3 (89.3  ± 1.7ｵ and 80.2 ± 5.9ｵ,  respectively) 
and CCR5 (58.6 ± 4.2ｵ and 67.2 ± 12.6ｵ, 
respectively), but low levels of CCR4 (1.4 ± 0.4ｵ 
and 4.5 ± 2.7ｵ,  respectively) (Fig.  2) ; CXCR3 
expression was greater than that of CCR5.  These 
results indicate that most CD4＋ and CD8＋ T cells in 
the ST of RA express Th1 cell-associated CXCR3 
and CCR5,  but not Th2 cell-associated CCR4.
　　Decreased frequencies of CXCR3- and 
CCR5-expressing CD4＋ T cells in the blood of 
RA.　 The frequencies of CXCR3-,  CCR5-,  and 
CCR4-expression in blood CD4＋ and CD8＋ T cells 
from 32 RA patients and 26 healthy controls (HC) 
were compared by ﬂ ow cytometric analysis. 
Representative staining patterns of these chemokine 
receptors in the CD4＋ and CD8＋ subpopulations in 
the RA patient and HC groups are shown in Fig.  3A 
and B,  respectively.  The mean ± SEM frequencies 
of CXCR3-expressing blood CD4＋ T cells were 
signiﬁ cantly decreased in RA patients (20.6 ± 1.6ｵ) 
compared with HC (32.8 ± 1.9 ｵ,  p ＜ 0.0001).  The 
frequencies of CCR5-expressing blood CD4＋ T cells 
were also signiﬁ cantly decreased in RA patients 
(15.3 ± 1.7ｵ) compared with HC (22.9 ± 2.2ｵ, 
p ＜ 0.005).  However,  there was no diﬀ erence in 
CCR4-expressing CD4＋ T cells between RA patients 
(10.5 ± 1.0ｵ) and HC (12.9 ± 1.5ｵ). Similarly, the 
frequency of CXCR3-expressing CD8＋ T cells in RA 
(39.2 ± 3.9) was decreased compared with HC 
(57.0 ± 3.7ｵ,  p ＜ 0.005) ; however,  no diﬀ erence 
was noted in CCR5 expression in CD8＋ T cells 
between the RA patients (41.1 ± 3.2) and HC 
(43.2 ± 2.4ｵ).  CCR4 expression in CD8＋ T cells 
was extremely limited (RA vs.  HC ; 2.6 ± 0.5 
vs.1.5 ＋ 0.4ｵ),  in agreement with previous 
observations [25] (Fig.  3C).  CXCR3 and CCR5-
coexpressing CD4＋ T cells were decreased in RA 
patients (7.7ｵ ± 2.3ｵ) compared with HC (17.8 ± 3.2
ｵ,  p ＜ 0.0005) ; however,  coexpression of CCR4 
and CCR5 was negligible.  These results indicate 
that Th1-type CD4＋ T cells are decreased in the 
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Fig. 2　　Quantiﬁ cation of CXCR3,  CCR5,  and CCR4 expression 
in CD4＋ and CD8＋ cells in the lymphocyte aggregate of RA tis-
sues.  The proportion of chemokine receptor expression in the 
CD4＋ and CD8＋ cell areas of ST sections from 3 RA patients was 
measured by analyzing the superimposed images from 3 diﬀ erent 
sections of each patient using OPTIMAS software.  The areas of 
lymphocyte aggregates in the sublining were identiﬁ ed by tracing 
the periphery of CD4＋ cell aggregates.  The area of chemokine 
receptors,  the CD4 or CD8 antigen,  and coexpression was identi-
ﬁ ed using the color threshold set for green,  red,  and yellow, 
respectively.  The proportion of chemokine receptors in the CD4＋ 
and CD8＋ T-cell population was calculated as follows ; chemokine 
receptor area (yellow) / CD4＋ or CD8＋ area (red plus yellow). 
Values are the mean ± SEM of a total of 9 tissue sections.
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peripheral blood of RA in terms of chemokine 
receptor expression.
　　Enhancement of CXCR3 and CCR5 
expression in blood CD4＋ T cells by IL-15 
stimulation.　 To determine the local regulation of 
CXCR3 and CCR5 expression in ST,  CD4＋ ,  and 
CD8＋ T cells from HC and RA patients after being 
stimulated with 10 ng/ml of IL-15 for 7 days,  we 
measured the surface expression of chemokine 
receptors by ﬂ ow-cytometric analysis.  The 
frequencies of CXCR3-,  CCR5-,  and CCR4-
expressing CD4＋ T cells in both RA patients and HC 
were signiﬁ cantly increased after IL-15 stimulation 
(Fig.  4).  CXCR3- and CCR5-expressing CD8＋ T 
cells were also increased,  but the eﬀ ects of IL-15 
stimulation were less prominent in CD8＋ T cells than 
in CD4＋ T cells (Fig.  4).  These results suggest that 
IL-15 may enhance T-cell expression of CXCR3 and 
CCR5 in the ST of RA.
　　We found that the number of cells was maintained 
after 7 days of IL-15 stimulation (with and without 
IL-15,  1.1 × 106/ml and 0.8 × 106/ml,  respectively). 
Consistent with this ﬁ nding,  the survival cell index 
of the cell culture with IL-15 relative to that with no 
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Fig. 3　　Expression of CXCR3,  CCR5,  and CCR4 in blood CD4＋ 
T cells and CD8＋ T cells from RA patients and healthy controls 
(HC).  Peripheral blood mononuclear cells (PBMCs) were stained 
directly or indirectly with anti-CXCR3 Ab (FITC),  anti-CCR4 Ab 
(FITC),  anti-CCR5 Ab (PE),  anti-CD4 Ab (Per-CP),  anti-CD8 Ab 
(Per-CP),  or isotype-matched control Ab,  and were analyzed by 
ﬂ ow cytometry.  Representative staining patterns of CXCR3,  
CCR5,  and CCR4 expression on CD4＋ and CD8＋ T-cell subpopu-
lations from RA patients and HC subjects are shown (A,  B).  The 
mean ± SEM % of CXCR3＋,  CCR5＋,  and CCR4＋ cells in CD4＋ 
and CD8＋ T cells from 31 RA patients and 26 HC subjects are 
shown (C).
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Fig. 4　　Enhancement of CXCR3,  CCR5,  and CCR4 expression in blood CD4＋ T cells from HC and RA patients after IL-15 stimula-
tion.  PBMCs from HC and RA patients (1 × 106/ml in RPMI 1640 culture medium with 10% FCS) were incubated for 7 days with or 
without IL-15 (10 ng/ml),  and CXCR3＋,  CCR5＋,  and CCR4＋ CD4＋ T cells were determined by ﬂ ow cytometric analysis. 
Representative staining patterns of CXCR3,  CCR5,  and CCR4 expression on CD4＋ T cell cells with or without IL-15 stimulation are 
shown (A).  Mean  ±  SEM percentages of CXCR3＋,  CCR5＋,  and CCR4＋ CD4＋ T cells from 31 RA patients and 26 HC subjects with 
or without IL-15 stimulation are shown (B).
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Fig. 5　　Enhancement of CXCR3,  CCR5,  and CCR4 expression in blood CD8＋ T cells from HC and RA patients after IL-15 stimula-
tion.  CXCR3＋,  CCR5＋,  and CCR4＋ CD8＋ T cells were determined by ﬂ ow cytometric analysis.  Representative staining patterns of 
CXCR3,  CCR5,  and CCR4 expression on CD8＋ T cell cells with or without IL-15 stimulation are shown (A).  Mean ± SEM percentages 
of CXCR3＋,  CCR5＋,  and CCR4＋ CD8＋ T cells from 31 RA patients and 26 HC subjects with or without IL-15 stimulation are shown 
(B).
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stimulation,  as determined by MTT assay,  was 
1.50 ± 0.14 (n ＝ 5).  Thus,  IL-15 appears to enhance 
T-cell survival.
Discussion
　　In the inﬂ amed ST of RA,  perivascular 
lymphocyte aggregates are frequently found,  with 
the Th1 cytokine IFN-ｺ being predominantly 
expressed [27].  We conﬁ rmed by 2-color 
immunoﬂ uorescence staining that high levels of 
CXCR3 and CCR5,  but low levels of CCR4,  were 
expressed in CD4＋ T cells localized to the 
lymphocyte aggregates of RA tissues.  In contrast, 
CXCR3 and CCR5 expression in peripheral blood 
CD4＋ T cells from RA patients was signiﬁ cantly 
decreased when compared with HC CD4＋ T cells, 
despite there being no diﬀ erence in CD4＋ T cell 
expression of CCR4.  On the other hand,  CD8＋ T 
cells were sparsely found in the periphery of CD4＋ 
T cell aggregates,  which also express CXCR3 and 
CCR5.
　　The accumulation of Th1-type CD4＋ T cells in 
ST lesions is thought to be induced by the clonal 
expansion and selective inﬁ ltration of Th1 cells.  In 
the ST of RA,  IL-12 and IL-18,  known to be crucial 
in Th1 cell activation,  are substantially expressed 
[28],  indicative of the local expansion of Th1 cells. 
On the other hand,  our study and others have shown 
that T cells strongly express CCR5 and CXCR3 [18, 
20,  29,  30].  In addition,  high concentrations of 
ligands for these receptors such as MIP-1ｸ [31], 
MIP-1ｹ [29],  RANTES [32],  IP-10[33,  34],  Mig 
[33,  35],  and ITAC [21] have been detected in the 
synovial ﬂ uid of active RA,  and these chemokines 
have been shown to be produced by macrophages and 
synovial ﬁ broblasts.  These ﬁ ndings suggest that the 
Th1 predominance in the ST may also be mediated 
by selective lymphocyte traﬃ  cking due to the 
preferential expression of CXCR3 and CCR5 on Th1 
cells and the local abundance of their agonistic 
ligands.
　　CXCR3 and CCR5 expression on blood T cells in 
RA patients remain controversial.  Some studies have 
demonstrated increased frequencies of CXCR3- and 
CCR5-expressing T cells [18],  which indicates the 
systemic deviation of T-cell responses toward the 
Th1 type in RA.  However,  others have found 
decreased frequencies of such T cells [20,  29,  36]. 
The reason for the diﬀ erences in these observations 
is unknown,  but our ﬂ ow cytometric analysis 
indicated the selective depletion of CXCR3- and 
CC5-expressing T cells in the blood compartment.  It 
is of interest that the accumulation of CXCR3＋ T 
cells in the blood was found in RA patients after 
TNF-ｸ inhibition with inﬂ iximab and etanercept [26]. 
These results indicate that CCR5- and CXCR3-
expressing T cells are actively recruited into 
inﬂ ammatory sites and that treatment with TNF-ｸ 
inhibition prevents Th1-cell inﬁ ltration into the ST 
by suppressing the expression of chemokines and 
adhesion molecules speciﬁ c to Th1 cell migration. 
We therefore believe that blood CXCR3＋ and 
CCR5＋ Th1 cells aggressively migrate into the ST 
when joint inﬂ ammation is severe,  resulting in a 
depletion of such Th1 cells in the blood compartment.
　　We found that IL-15,  the cytokine known to be 
responsible for T-cell activation in RA joints, 
enhances the expression of all CXCR3,  CCR5,  and 
CCR4 on CD4＋ and CD8＋ T cells,  as well as their 
cell survival.  These results correspond with those of 
a previous study demonstrating induction of CCR4 
and CCR5 expression in IL-15-activated T cells [25]. 
Thus,  IL-15 appears to activate T cells to express 
both Th1 cell- and Th2 cell-associated chemokine 
receptors.  In the ST of RA,  where Th1 cells are 
already enriched due to their selective recruitment, 
IL-15 may play a role in enhancing or maintaining 
CXCR3 and CCR5 expression in CD4＋ T-cell 
inﬁ ltrates.  This upregulation of chemokine receptors 
may be crucial to the organized distribution of Th1-
type CD4＋ T cells in the ST,  which depends on 
chemokine expression.  IL-15 has recently been 
shown to enhance CD40L and CCR5 expression in 
RA T cells and to promote the secretion of the 
chemokine MAP-1ｸ.  The key roles of IL-15 in RA 
pathogenesis have been well-supported [37,  38],  and 
AMG 714,  a human anti-IL-15 antibody,  appears to 
ameliorate disease activity in RA patients [39].  The 
reduction in Th1 responses in response to IL-15 
blockade may be one of the mechanisms responsible 
for its eﬃ  cacy.
　　In summary,  CXCR3- and CCR5-expressing 
CD4＋ T cells predominate in the lymphoid aggregates 
of RA tissues,  and such CD4＋ T cells are decreased 
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in the blood compartment,  presumably due to active, 
selective recruitment of Th1 cells into the ST by the 
local abundance of CXCR3 and CCR5 agonistic 
chemokines.  IL-15 may play a role in the 
organization of CD4＋ T cells through chemokine 
receptor enhancement after migration.
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